Star commercial academy appoints director
March 28, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Star
Gary Lunt has been appointed to the newly created role of Business Development director with training agency STAR Commercial Academy. …
New ‘culture of compassion’ for NHS
March 27, 2013Sales and Marketing Francis, Francis report, Hunt, Mid Staffs, NHS, Staffs
The government has launched plans to ensure that the needs of patients are paramount in any future dealings with the …
FDA delays GSK flu vaccine
March 27, 2013Research and Development, Sales and Marketing FDA, GSK, Vaccine
The FDA has cooled on GlaxoSmithKline’s latest vaccine for a bird flu pandemic, Q-Pan H5N1, despite a vote of confidence …
Multiple sclerosis rivals gain EU approval
March 27, 2013Research and Development, Sales and Marketing Biogen IDEC, Genzyme, MS
Rival MS treatments from Biogen Idec and Genzyme have both received European approval. The CHMP has recommended marketing authorisation for …
Chiltern announces two promotions
March 26, 2013Manufacturing and Production, Research and Development, Sales and Marketing chiltern
Global clinical contract research organisation Chiltern International has announced the promotions of Stuart McGuire and Jim Szymeczek.“I am pleased to …
AstraZeneca settles Crestor case
March 26, 2013Sales and Marketing AstraZeneca, Crestor, Watson
AstraZeneca has settled a long-running legal battle over one of its biggest brands, Crestor, whose patent expires in 2016. The …
Sanofi in immunotherapy tie-up
March 26, 2013Research and Development, Sales and Marketing Transgene, snaofi
Sanofi has signed a 15-year deal with biopharma company Transgene to produce a platform to help create a range of …
Africa rising
March 26, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Africa, Lunt
Africa has been a byword for poverty, disease and political turmoil for generations, and many people in the most developed …
New chief executive for Eyevensys
March 26, 2013Manufacturing and Production, Research and Development, Sales and Marketing Eyevensys
Gene therapy development firm Eyevensys has announced the appointment of Dr Ivan Cohen-Tanugi as chief executive.Cohen-Tanugi has over 20 years’ …
Xarelto gets EU nod
March 25, 2013Sales and Marketing Bayer, Xarelto
Bayer HealthCare has been given a boost by the recommendation in Europe of its oral blood thinner Xarelto to prevent …
LEO Pharma appoints two divisional directors
March 25, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing LEO Pharma
LEO Pharma has made two new appointments to the leadership team of its UK/Ireland affiliate.Mike Williams (pictured) joins to head …
AstraZeneca hires strategy boss
March 25, 2013Sales and Marketing AstraZeneca, dunoyer
AstraZeneca has poached one of GlaxoSmithKline’s senior executives to help push through its new growth strategy. Marc Dunoyer, global head …
Actavis to invest in Florida facility
March 25, 2013Manufacturing and Production Actavis, Watson
Actavis has announced a $40.5 million investment round at its plant in Davie, Florida, that looks set to create around …
Two Apotex facilities cited by FDA
March 25, 2013Manufacturing and Production Apotex, FDA
Canadian generic drugmaker Apotex has been sent another warning letter by the FDA after violations were uncovered at two manufacturing …
Contract research news in brief
March 22, 2013Research and Development Calvert labs, Frontage Labs, Medrio, Mytrus, Particle Sciences, Sotio, chiltern, inVentiv Health
inVentiv takes stake in Mytrus, Frontage Labs FDA-inspected, plus updates from Chiltern, Calvert Labs/Particle Sciences and Medrio.
Pharma manufacturing news in brief
March 22, 2013Manufacturing and Production APIC, Agila, Avitide, Catalent, Contego, Malaysian Bio-XCell, Nueland Labs, ShangPharma, Zhejiang biotech
Agila to build a new facility in Malaysia, Avitide raises money for new bioprocessing technology, plus alliance and acquisition news …
Merck KGaA/BMS China deal
March 22, 2013Sales and Marketing BMS, Merck KGaA, diabetes
Merck KGaA and Bristol-Myers Squibb are to co-promote the German firm’s veteran diabetes drug Glucophage in different formations in China. …
Two new appointments at PAN
March 22, 2013Medical Communications, Sales and Marketing Pan, advertising
Creative agency PAN has welcomed two new team members in senior copywriter Sarah White and account manager Rachel Flavell. White …
NICE to assess drug value
March 22, 2013Sales and Marketing EMIG, NHS, NICE, VBP
NICE will be responsible for assessing the full value of medicines – taking into account their benefit to patients and …
AstraZeneca sets out growth strategy
March 21, 2013Sales and Marketing AstraZeneca, R&D
AstraZeneca has set out an ambitious plan designed to return it to growth which eschews diversification and sets great store …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
